Episode 64: Michael Peluso, M.D. – Viral reservoirs and Monoclonal Antibody treatment trial

TLC Sessions - Living with Long Covid

コンテンツは TLC Sessions によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャストコンテンツは、TLC Sessions またはそのポッドキャストプラットフォームパートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。

7M ago 1:02:09

MP3•エピソードのホーム

Michael Peluso M.D., an HIV and infectious disease specialist at UCSF, has been studying Long Covid patients since April 2020 (LIINC Study). This, along with his history of working with HIV and other viruses, has given him the knowledge and methods to make some break-throughs into Long Covid pathogenesis, effects and, potentially, treatments. He, along with his team, has established that Long Covid causes T-cell and immune dysregulation and he has used multimodal molecular imaging to reveal that viral RNA reservoirs are persistent in Long Covid patients. With the aim of clearing this viral debris, Peluso is now leading a clinical trial using a monoclonal antibody infusion.
Living with Long Covid? How was your week?
Website - https://www.tlcsessions.net/
Twitter - @SessionsTlc https://twitter.com/sessionstlc
Insta - @tlcsessions https://www.instagram.com/tlcsessions